Adalimumab

• Description:

  Adalimumab anti-TNF-alpha) is the first fully human recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  148 kDa

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  TNF

• CAS Number:

  331731-18-1